4 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow albuferon: new trials by email Literature Review of albuferon trials Research Report on albuferon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals Albinterferon, Ribavirin, Albuferon - HIV Infections, HCV | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 41 | 2007-06-18 | 2017-07-02 |
| A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 Albuferon, Ribavirin - Chronic Hepatitis C | Phase 2 | Completed | Human Genome Sciences Inc. | 43 | 2005-11-01 | 2013-08-02 |
| A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 Albuferon, Ribavirin, PEG-IFNalfa2a - Hepatitis C, Chronic | Phase 2 | Completed | Human Genome Sciences Inc. | 458 | 2005-05-01 | 2013-11-07 |
| A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C Albuferon, Ribavirin - Hepatitis C | Phase 2 | Completed | Human Genome Sciences Inc. | 115 | 2004-10-01 | 2013-08-02 |
Hepatitis C (4) · Hepatitis C, Chronic (2) · Bronchiolitis Obliterans Syndrome (1) · Fibrosis (1) · HIV Infections (1)
Human Genome Sciences Inc. (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Canada (2) · United States (2) · Australia (1) · Czechia (1) · France (1) · Germany (1) · Israel (1) · Poland (1) · Romania (1)